Mirae Asset Mutual Fund

Mirae Asset Healthcare Fund Direct-Growth

Equity: Sectoral-Pharma - Growth (Open ended)
Mirae Asset Healthcare Fund Direct-GrowthNAV: 52.13 as on 06 Sep, 2026
Risk levelCategoryBenchmark
Copyright © 2026 sharpely. All rights reserved.
Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: BSE Healthcare Total Return IndexCheck Portfolio Overlap →
NAV: ₹52.13+0.64%
07 Sept 2026

Rolling Returns Analysis

Rolling annualized returns of Mirae Asset Healthcare Fund Direct-Growth across 1Y, 3Y and 5Y windows — average, best, worst returns and percentage of positive return periods.
Metric1 Yr Rolling Returns3 Yr Rolling Returns5 Yr Rolling Returns7 Yr Rolling Returns
Analysis period10 Jul, 2019 - 07 Sep, 202619 Jul, 2021 - 07 Sep, 202627 Jul, 2023 - 07 Sep, 202607 Aug, 2025 - 07 Sep, 2026
Average returns25.59%24.04%23.87%23.31%
Standard deviation24.92%5.46%5.28%1.44%
Best returns90.84%
1 year ending on 25 Mar, 2021
36.28%
3 years ending on 03 Aug, 2021
33.88%
5 years ending on 17 Sep, 2024
26.72%
7 years ending on 31 Aug, 2026
Worst returns-10.66%
1 year ending on 06 Jan, 2023
13.14%
3 years ending on 26 Oct, 2023
15.08%
5 years ending on 02 Feb, 2026
21.32%
7 years ending on 16 Oct, 2025
Period with positive return81.99%100.00%100.00%100.00%
Period with return > 5%72.71%100.00%100.00%100.00%
Period with return > 10%67.72%100.00%100.00%100.00%
Period with return > 15%62.17%99.05%100.00%100.00%
Beat % Category65.23%63.06%92.31%100.00%
Beat % Benchmark80.29%84.29%99.87%100.00%

Trailing Returns

Point-to-point returns of Mirae Asset Healthcare Fund Direct-Growth vs category average for YTD, 1M, 6M, 1Y, 3Y, 5Y and 10Y periods — with category rank and total funds count.
0%
10%
20%
30%
40%
21.6%
19.0%
18.1%
YTD
0.8%
0.4%
0.5%
1 M
18.6%
19.3%
16.5%
6 M
20.8%
18.3%
22.7%
1 Y
22.9%
22.8%
47.3%
3 Y
15.7%
15.7%
14.0%
5 Y
15.3%
9.4%
10 Y
Fund
Equity: Sectoral-Pharma
BSE Healthcare Total Return Index
NameYTD1 M6 M1 Y3 Y5 Y10 YSince Inception
Fund21.62%0.82%18.57%20.80%22.85%15.73%-22.34%
Equity: Sectoral-Pharma19.02%0.44%19.32%18.26%22.79%15.66%15.35%-
BSE Healthcare Total Return Index18.07%0.52%16.54%22.74%47.28%13.97%9.42%-
Rank in category9813944--
Funds in category222322211184-

Period Returns

Calendar-year, quarterly and monthly return history of Mirae Asset Healthcare Fund Direct-Growth. Toggle between bar chart and table view to analyse periodic performance trends.

Historical Performance

Track NAV movement and cumulative returns of Mirae Asset Healthcare Fund Direct-Growth across 1M, 6M, 1Y, 3Y, 5Y and since-inception periods. Compare SIP and lumpsum growth over time.

Compare performance with respect to
Add benchmark

Frequently Asked Questions

What are the 1-year returns of Mirae Asset Healthcare Fund Direct-Growth?
Mirae Asset Healthcare Fund Direct-Growth has delivered a 1-year return of 20.80% as of 6 Sep 2026. During the same period, its benchmark BSE Healthcare Total Return Index returned 22.74%. The fund has underperformed its benchmark over this period.
What are the 3-year returns of Mirae Asset Healthcare Fund Direct-Growth?
Mirae Asset Healthcare Fund Direct-Growth has delivered a 3-year CAGR of 22.85% as of 6 Sep 2026. Its benchmark BSE Healthcare Total Return Index returned 47.28% CAGR over the same period. CAGR (Compounded Annual Growth Rate) is the right way to evaluate multi-year mutual fund performance as it smooths out year-to-year volatility.
What are the 5-year returns of Mirae Asset Healthcare Fund Direct-Growth?
Mirae Asset Healthcare Fund Direct-Growth has delivered a 5-year CAGR of 15.73% as of 6 Sep 2026. Its benchmark BSE Healthcare Total Return Index returned 13.97% CAGR over the same period. A 5-year track record is considered a more reliable indicator of fund quality than shorter-term performance, as it captures at least one full market cycle.
What are the returns of Mirae Asset Healthcare Fund Direct-Growth since inception?
Since its launch on 3 Jul 2018, Mirae Asset Healthcare Fund Direct-Growth has delivered a CAGR of 22.34%. Since-inception returns reflect the fund's full history and give the most complete picture of long-term performance.
How has Mirae Asset Healthcare Fund Direct-Growth performed vs its category over the long term?
Over the long term, Mirae Asset Healthcare Fund Direct-Growth has ranked 4 out of 11 funds in the Equity: Sectoral-Pharma category on a 3-year basis, and 4 out of 8 funds on a 5-year basis. Category rank is one of several factors to consider alongside risk metrics and rolling return consistency when evaluating a fund.
What is the Sharpe ratio of Mirae Asset Healthcare Fund Direct-Growth?
The Sharpe ratio of Mirae Asset Healthcare Fund Direct-Growth is 1.07 (as of 6 Sep 2026). The Sharpe ratio measures how much return the fund generates per unit of risk (volatility) taken. A Sharpe ratio above 1.0 is generally considered good — the higher the ratio, the better the risk-adjusted return.
What is the alpha of Mirae Asset Healthcare Fund Direct-Growth?
The 3Y alpha of Mirae Asset Healthcare Fund Direct-Growth is 1.01% (as of 6 Sep 2026). Alpha measures the excess return generated by the fund over and above its benchmark BSE Healthcare Total Return Index, after adjusting for risk. A positive alpha means the fund manager has added value beyond what the market delivered. A negative alpha means the fund has underperformed its benchmark on a risk-adjusted basis.
What is the beta of Mirae Asset Healthcare Fund Direct-Growth?
The beta of Mirae Asset Healthcare Fund Direct-Growth is 0.97 (as of 6 Sep 2026). Beta measures how sensitive the fund is to market movements relative to its benchmark BSE Healthcare Total Return Index. A beta of 1 means the fund moves in line with the market. A beta above 1 means it is more volatile than the market; below 1 means it is less volatile. Mirae Asset Healthcare Fund Direct-Growth's beta of 0.97 indicates it is more defensive than its benchmark.
What are the rolling returns of Mirae Asset Healthcare Fund Direct-Growth?
The average 1-year and 3-year rolling returns of Mirae Asset Healthcare Fund Direct-Growth is 25.59% and 24.04% respectively. Rolling returns show the fund's annualized return across every possible 1-year and 3-year investment window, making them a far more reliable measure of consistency than point-to-point returns, which depend heavily on the start and end date chosen.